MedTrace Logo

Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment

NCT05326399 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 369

Last updated 2025-11-28

No results posted yet for this study

Summary

Investigators will conduct this single-center, prospective cohort study to explore the prevalence and risk factors of renal function progression in post-liver transplantation patients with renal impairment after renal biospy and to understand the the pathology of kidney disease in post-liver transplantation patients with renal impairment.

Conditions

  • Liver Transplantation
  • Renal Insufficiency, Chronic

Interventions

BEHAVIORAL

renal biospy

Standard percutaneous biopsy has been performed in all participants. Modification of treatment will be jointly decided by hepatologists and nephrologists based on the pathological results. All participants will be followed up for 96 weeks.

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2027-05-31
Completion
2030-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05326399 on ClinicalTrials.gov